Changes in Serum Markers of Inflammation and Endothelial Activation in HIV-Infected Antiretroviral Naive Patients Starting A Treatment with Abacavir-Lamivudine or Tenofovir-Emtricitabine Plus Efavirenz

MLA

Calza, Leonardo, et al. “Changes in Serum Markers of Inflammation and Endothelial Activation in HIV-Infected Antiretroviral Naive Patients Starting A Treatment with Abacavir-Lamivudine or Tenofovir-Emtricitabine Plus Efavirenz.” Current HIV Research, vol. 14, no. 1, Jan. 2016, pp. 61–70. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edo&AN=ejs37244073&authtype=sso&custid=ns315887.

APA

Calza, L., Magistrelli, E., Danese, I., Colangeli, V., Borderi, M., Bon, I., Re, M., Mancini, R., Conti, M., Motta, R., & Viale, P. (2016). Changes in Serum Markers of Inflammation and Endothelial Activation in HIV-Infected Antiretroviral Naive Patients Starting A Treatment with Abacavir-Lamivudine or Tenofovir-Emtricitabine Plus Efavirenz. Current HIV Research, 14(1), 61–70.

Chicago

Calza, Leonardo, Eleonora Magistrelli, Ilaria Danese, Vincenzo Colangeli, Marco Borderi, Isabella Bon, Maria Re, et al. 2016. “Changes in Serum Markers of Inflammation and Endothelial Activation in HIV-Infected Antiretroviral Naive Patients Starting A Treatment with Abacavir-Lamivudine or Tenofovir-Emtricitabine Plus Efavirenz.” Current HIV Research 14 (1): 61–70. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edo&AN=ejs37244073&authtype=sso&custid=ns315887.